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INTRODUCTION
Except for the pseudoautosomal region, all other
Y-linked loci on the non-recombining part of the
Y-chromosome are haploid and paternally inherited
(1).Thus, Y-chromosome markers are transmitted
as haplotypes from fathers to sons throughout generations
establishing patrilineages (2).These characteristics
should render the Y-linked polymorphisms extremely
useful as genetic tools for human evolution, forensic
and other population genetic studies (3-6).
In 1996, Nakahori hypothesized that during the
evolution of sex chromosomes, only the genes that
are preferable to the male phenotype migrated to the
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Y-chromosome. These are suggested to be the genes
and factors specific for growth advantage and sperm-
atogenesis (7). Since then, many studies were conducted
to verify this hypothesis and clarify the male phenotypes
that are associatedwith specific Y-chromosomal geno-
types. Many studies correlated adult stature and male
infertility phenotypes to the Y-chromosomal structural
variations (8 -10). Kuroki et al., (1999), reported that the
spermatogenic ability varies amongmales fromdifferent
Y-chromosomal lineages (11). Another study is being
prepared by the same research group suggesting a
relation between variations in the bodymass index (BMI)
among males and different human Y-chromosomal
haplotypes (12).
In the present studywe investigatedwhether there are
differences amongmales from different Y-chromosomal
lineages regarding their susceptibility or resistance
to prostate cancer.
The humanY-chromosome shareswith both testicular
and prostate cancers the criterion of beingmale specific;
and there are no studies that correlate Y-chromosomal
genotypes with the incidence of male specific cancers
(13).
We used a previously reported Y-linked tetranucleotide
polymorphic microsatellite marker DYS19, which is
known for its five different alleles among populations
(14) to classify Japanese prostate cancer patients and
normal controlmales residing in the samegeographical
areas. The section of results of this paper presents the
frequency distribution of DYS19 alleles amongmales
from different populations including Japanese males.
In addition, these findings show a significant difference,
using the chi-Squared test, between prostate cancer
Japanese cases and normal controls indicating variations
of susceptibility or resistance for havingprostate cancer
amongmales with specific alleles of theDYS19marker.
MATERIALS AND METHODS
DNA samples . Genomic DNA was prepared from
the available prostate cancer specimens according to
the standard method (15). From both the urology and
pathology departments of Tokushima University,73
prostate cancer tissue specimens were obtained from
frozen samples or paraffin embedded samples. From
Saint Marianna University hospital, 24 DNA samples
were provided by Prof. T. Iwamoto. Seven samples were
difficult to amplify because of the poor condition of the
DNA, so the study was based on 90 Japanese prostate
cancer samples. The ages of the patients ranged from
52 years to 88 years with a mean and standard deviation
of 70.9+9.2 years.
For controls, DNA was prepared from peripheral
leucocytes of healthy blood donors. Eighty controls
were from Tokushima while 19were fromSt.Marianna
University hospital, Kawasaki, Japan. Hence, a total
of 99 Japanese healthy control males were studied.
The ethical committee of the University of Tokushima,
School of Medicine, approved this study.
DNA from the above Japanese samples were geno-
typed for their alleles of a Y-chromosomal specific
microsatellite marker DYS19. In addition, DNA samples
were available for 71 Bolivian high altitude, 99 Bolivian
low altitude, and 99 Asianmales for comparison purposes
regarding DYS19 allelic distribution. All samples had
been offered by collaborators and were collected
according to approved human subject protocols.
DYS19 microsatellite genotyping. Genotyping of
Y-chromosomes from different populations for DYS19
was done using anABI 377 sequencer. The PCR reaction
contained a primer pair, one of whichwas end-labeled
with a fluorescent dye, TET. DNA sampleswere amplified
by PCR in a volume of 10 µl containing 66 ng genomic
DNA, 67mM tris-HCl (pH 8.3), 3mMMgCl2, 16.6 mM
(NH4) SO4, 0.1mMdNTPs, 0.25 µMof each primer and
1U Taq Gold DNA polymerase. Thermocycling was
performed using a PE 9600 thermocycler under the
following conditions : Initial denaturation at 95℃ for
14 mins, followed by 30 cycles of denaturation at 94℃
for 1 min, annealing at 54℃ for1min, and extension at
72℃ for 30 secs. The final extension step was at 72℃
for 10 mins. PCR products were resolved with urea
denaturing polyacrylamide gels on the ABI sequencer
using an internal size standard in each lane. Raw geno-
type data were collected using GENESCAN software
(ABI), and gel files were analyzedwith the GENOTYPER
software package (ABI).
The following primer set was used for PCR, the
forward primer was labeled with TET :
DYS 19-F : 5’-CTACTGAGTTTCTGTTATAGT-3’
DYS 19-R : 5’-ATGGCATGTAGTGA GGACA-3’
RESULTS AND DISCUSSION
Roewer et al. (1992) reported the first humanY-linked
polymorphic microsatellite, DYS19, containing a
(GATA)n motif (16). Santos et al. (1993) found five
different alleles (A-E) with sizes varying from 186 to
202 bp, respectively. They estimated the gene diversity as
0.66 among the Brazilian population with no mutations
detected in 100 father and son pairs (17). DYS19 has
been used in crime investigations and paternity testings
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In 1996 Santos et al. reported the striking geographical
differences in the distribution of allele frequencies of
DYS19 microsatellite polymorphism with the detection
of three new alleles. They reported that Amerindians
showed an overwhelming predominance of the A allele,
while in Caucasians the B allele was most common,
and in Asians and Africans allele C was predominant
(14).
Kayser et al. 1997, evaluated the Y-chromosomal
short tandem repeats (STRs) in a multi-center study
and showed that DYS19 is a very useful marker for
forensic and population genetic studies. They presented
the full data about many STRs including the DYS19,
with its repeated motif (GATA)n, and the number of
repeats ranging from 10 to 19 with ten alleles ranging
in size from 174 to 210 bp and a gene diversity of 0.72
(20).
In the present study, we found only five alleles among
all Japanese males. They were the famous five alleles
(A-E) with sizes varying from 186-202 bp (Figure 1).
The frequency distributions of the alleles of the Y-
linked microsatellite polymorphic marker DYS19
among males from different populations including
Japanese males are presented in Table 1. Then, we
studied the Japanese patients with prostate cancer for
the DYS19 allelic distribution. We detected different
frequencies for each DYS19 allele among these
patients. On comparing DYS19 allele frequencies
between prostate cancer patients and normal controls we
found that Japanese males with the D allele of DYS19
have a significantly lower incidence of prostate cancer
than males with other alleles of DYS19 (p = 0.002); the
Odds Ratio was 0.26 with a 95 % confidence interval
of (0.65-3.71). On the other hand,maleswho hadDYS19
allele C showed a significantly higher risk to develop
prostate cancer, which was obvious from the significant
difference when comparing the frequency of this C
allele between patients and control subjects (p=0.02).
The Odds Ratio was 2.04 with a 95% confidence interval
of (0.75-2.42), compared withmales having other alleles
(Table 2). These findings support our hypothesis that
Table 1. Frequency distribution of the alleles of the Y-linked
microsatellite polymorphic marker DYS19 among males from
different populations
DYS 19 allele
A
（１８６bp)
％
B
（１９０bp)
％
C
（１９４bp)
％
D
（１９８bp)
％
E
（２０２bp)
％
Other
alleles
％
Japaneseａ 7.1 3.0 49.5 24.2 16.2 0
Asiansａ 4 21 45 20 9 1
Africansｂ 6 20 31 26 14 3
N. Americansｃ 57 32 11 0 0 0
Caucasiansｄ 6 40 27 20 7 0
Bolivians H. A.ａ 75 25 0 0 0 0
Bolivians L. A.ａ 71 22 4 1 2 0
N. Americans =Native Americans.
Bolivians H.A=Bolivian high altitude.
Bolivians L.A =Bolivian low altitude.
a represents the present findings of this investigation
b, c and d represents findings from Santos et al ., 1996.
Table 2. Frequency distribution of the alleles of the Y-linked
microsatellite polymorphic marker DYS19 among Japanese males
with prostate cancer and their matched controls
DYS 19
alleles
Prostate
cancer
Patients
Normal
controls
Odds Ratio (O.R.)
(95% Confidence Interval)
A allele (186 bp) 3 7 N.S
B allele (190 bp) 6 3 N.S
C allele (194 bp) 60＊ 49 2.04 (0.75-2.42)
D allele (198 bp) 7＊＊ 24 0.26 (0.65-3.71)
E allele (202 bp) 14 16 N.S
Totals 90 99
N.S.= non significant.
＊p=０．０２
＊＊p=０．００２
Fig.1. GeneScan results for the Y-linked tetranucleotide micro-
satellite DYS19 polymorphism. Five alleles were detected in Japanese
males. A, B, C, D, and E alleles with sizes186, 190, 194, 198 and
202 bp, are presented respectively.
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male descendants fromdifferentY-chromosomal origins
are different regarding their susceptibility or resistance
to develop prostate cancer, as a male-specific cancer.
The well documented familial clustering of prostate
cancer and the significance of familial factors that were
emphasized bymany studies support the present findings
(21-24). Steinberg et al. (1990) investigated the frequency
of prostate cancer in the relatives of 691 males with
prostate cancer and 640 of their spouses. In 15% of
the cases, it was a father or brother affected with
prostate cancer (P > 0.001).Maleswith a father or brother
affectedwere twice as likely to develop prostate cancer
as men with no relatives affected.Moreover, twin studies
support the existence of a significant genetic factor.
They also found a trend of increasing riskwith increasing
number of affected family members, such that males
with 2 or 3 first-degree relatives affected had a 5-and
11-fold increased risk of developing prostate cancer,
respectively (25).
Among the unselected group of 6,390 males, in the
region of Quebec City, Narod et al. (1995) found that
the prevalence of prostate cancer was increased in those
males with any first-degree relative affected (prevalence=
6.7% ; relative risk=1.72 as compared with those men
with no first-degree relative affected. The increase
in the relative risk was mostly contributed by affected
brothers (prevalence=10.2% ; relative risk=2.62 ; P=0.0002)
(26). All these studies emphasized the sharing of the
first-degree relatives, especially fathers and brothers
in the risk of prostate cancer. Any prostate cancer affected
patient shares the same genetic background with his
father and brothers, especially the Y-chromosome,which
is transmitted exclusively from fathers to sons without
any recombination events. We hypothesized that the
Y-chromosomal genes and locimay act as a determinant
in the process of inherited vulnerability to prostate
cancer.
These findings do not represent a causal relationship
between the DYS19 allelic frequency and incidence
of prostate cancer, but rather it supports the hypothesis
that males from different Y-chromosomal lineages
are different regarding their phenotypes including
their susceptibility or resistance for male specific
cancers.
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